Subbu Nambi
Stock Analyst at Guggenheim
(4.87)
# 160
Out of 5,113 analysts
70
Total ratings
75%
Success rate
22.62%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TWST Twist Bioscience | Maintains: Buy | $77 → $79 | $42.27 | +86.89% | 3 | Jan 26, 2026 | |
| SOPH SOPHiA GENETICS | Maintains: Buy | $6 → $7 | $5.22 | +34.10% | 2 | Jan 26, 2026 | |
| PSNL Personalis | Maintains: Buy | $12 → $13 | $10.37 | +25.36% | 2 | Jan 26, 2026 | |
| ILMN Illumina | Maintains: Buy | $144 → $170 | $151.25 | +12.40% | 5 | Jan 26, 2026 | |
| GRAL GRAIL | Maintains: Buy | $100 → $130 | $106.38 | +22.20% | 3 | Jan 26, 2026 | |
| GH Guardant Health | Maintains: Buy | $115 → $135 | $114.09 | +18.33% | 8 | Jan 26, 2026 | |
| CSTL Castle Biosciences | Maintains: Buy | $43 → $47 | $42.63 | +10.25% | 3 | Jan 26, 2026 | |
| BRKR Bruker | Maintains: Buy | $53 → $58 | $48.21 | +20.31% | 5 | Jan 26, 2026 | |
| ADPT Adaptive Biotechnologies | Maintains: Buy | $20 → $21 | $19.16 | +9.60% | 2 | Jan 26, 2026 | |
| NEOG Neogen | Maintains: Buy | $8 → $12 | $10.25 | +17.07% | 4 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $50 | $39.73 | +25.85% | 5 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $230 → $270 | $239.48 | +12.74% | 3 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $275 | $235.25 | +16.90% | 3 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $102.46 | - | 4 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $170 | $97.10 | +75.08% | 2 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $114.53 | - | 1 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $95 | $66.60 | +42.64% | 4 | Sep 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $25.30 | +42.29% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $10.08 | -0.74% | 1 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.80 | - | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $2.22 | +170.27% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $21.98 | - | 3 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $161.75 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $2.51 | - | 1 | Dec 14, 2023 |
Twist Bioscience
Jan 26, 2026
Maintains: Buy
Price Target: $77 → $79
Current: $42.27
Upside: +86.89%
SOPHiA GENETICS
Jan 26, 2026
Maintains: Buy
Price Target: $6 → $7
Current: $5.22
Upside: +34.10%
Personalis
Jan 26, 2026
Maintains: Buy
Price Target: $12 → $13
Current: $10.37
Upside: +25.36%
Illumina
Jan 26, 2026
Maintains: Buy
Price Target: $144 → $170
Current: $151.25
Upside: +12.40%
GRAIL
Jan 26, 2026
Maintains: Buy
Price Target: $100 → $130
Current: $106.38
Upside: +22.20%
Guardant Health
Jan 26, 2026
Maintains: Buy
Price Target: $115 → $135
Current: $114.09
Upside: +18.33%
Castle Biosciences
Jan 26, 2026
Maintains: Buy
Price Target: $43 → $47
Current: $42.63
Upside: +10.25%
Bruker
Jan 26, 2026
Maintains: Buy
Price Target: $53 → $58
Current: $48.21
Upside: +20.31%
Adaptive Biotechnologies
Jan 26, 2026
Maintains: Buy
Price Target: $20 → $21
Current: $19.16
Upside: +9.60%
Neogen
Jan 9, 2026
Maintains: Buy
Price Target: $8 → $12
Current: $10.25
Upside: +17.07%
Jan 5, 2026
Maintains: Buy
Price Target: $45 → $50
Current: $39.73
Upside: +25.85%
Jan 5, 2026
Maintains: Buy
Price Target: $230 → $270
Current: $239.48
Upside: +12.74%
Jan 5, 2026
Maintains: Buy
Price Target: $250 → $275
Current: $235.25
Upside: +16.90%
Nov 21, 2025
Downgrades: Neutral
Price Target: n/a
Current: $102.46
Upside: -
Oct 29, 2025
Maintains: Buy
Price Target: $115 → $170
Current: $97.10
Upside: +75.08%
Oct 16, 2025
Initiates: Neutral
Price Target: n/a
Current: $114.53
Upside: -
Sep 26, 2025
Maintains: Buy
Price Target: $80 → $95
Current: $66.60
Upside: +42.64%
Aug 13, 2025
Maintains: Buy
Price Target: $32 → $36
Current: $25.30
Upside: +42.29%
Apr 16, 2025
Reiterates: Buy
Price Target: $10
Current: $10.08
Upside: -0.74%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $5.80
Upside: -
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $2.22
Upside: +170.27%
Jun 26, 2024
Downgrades: Neutral
Price Target: n/a
Current: $21.98
Upside: -
Jun 18, 2024
Initiates: Neutral
Price Target: n/a
Current: $161.75
Upside: -
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $2.51
Upside: -